Cargando…

Genomic profile and immune microenvironment in patients with relapsed stage IA lung adenocarcinoma

Patients with early-stage non-small cell lung cancer (NSCLC), even stage IA, are at substantial risk of relapse and death. We explored the distinct features of molecular alterations and immune-related gene expression in Formalin-fixed paraffin-embedded (FFPE) samples from 25 relapsed patients compar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Lu, Zhang, Jing, Song, Yane, Yang, Guangjian, Xu, Haiyan, Li, Junling, Guo, Lei, Li, Xin, Shi, Xinying, Mao, Beibei, Yang, Ying, Wu, Lijia, Wei, Jiyu, Zhang, Henghui, Ying, Jianming, Wang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689326/ https://www.ncbi.nlm.nih.gov/pubmed/33221686 http://dx.doi.org/10.1016/j.tranon.2020.100942

Ejemplares similares

Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases
por: Zhou, Yuan, et al.
Publicado: (2021)

Tumor Differentiation and EGFR Mutation Associated with Disease-Free Survival in Stage IA Lung Adenocarcinoma Patients with Curative Surgery
por: Yang, Lu, et al.
Publicado: (2020)

Nomograms for intraoperative prediction of lymph node metastasis in clinical stage IA lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2023)

Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade
por: Wang, Shuhang, et al.
Publicado: (2022)

Role of breath-hold lung PET in stage IA pulmonary adenocarcinoma
por: Cheng, Zhaoping, et al.
Publicado: (2023)

EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma
por: Chen, Zhiming, et al.
Publicado: (2020)

The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma
por: Yang, Lu, et al.
Publicado: (2020)

The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses
por: Zhou, Pei, et al.
Publicado: (2020)

The mutational pattern of homologous recombination (HR)-associated genes and its relevance to the immunotherapeutic response in gastric cancer
por: Fan, Yue, et al.
Publicado: (2020)

Varied Pathways of Stage IA Lung Adenocarcinomas Discovered by Integrated Gene Expression Analysis
por: Chen, Chengwen, et al.
Publicado: (2011)

Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2017)

Sublobectomy for stage IA1‐2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25
por: Qi, Yi‐Fan, et al.
Publicado: (2022)

Segmentectomy or Wedge Resection in Stage IA Lung Squamous Cell Carcinoma and Adenocarcinoma?
por: Li, Guoshu, et al.
Publicado: (2021)

CT Features of Stage IA Invasive Mucinous Adenocarcinoma of the Lung and Establishment of a Prediction Model
por: Zhang, Xiuming, et al.
Publicado: (2022)

Crizotinib vs platinum‐based chemotherapy as first‐line treatment for advanced non‐small cell lung cancer with different ROS1 fusion variants
por: Xu, Haiyan, et al.
Publicado: (2020)

Intrapulmonary lymph node metastasis is common in clinically staged IA adenocarcinoma of the lung
por: Zhang, DengGuo, et al.
Publicado: (2018)

Detection of oncogenic mutations in resected bronchial margins by next-generation sequencing indicates early relapse in stage IA lung adenocarcinoma patients
por: Lv, Tangfeng, et al.
Publicado: (2017)

Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences
por: Xu, Fei, et al.
Publicado: (2022)

Novel genetic characteristics in low‐grade fetal adenocarcinoma of the lung
por: Zhang, Shuyang, et al.
Publicado: (2021)

Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer
por: Zhang, Libin, et al.
Publicado: (2021)

Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma
por: Sun, Fenghao, et al.
Publicado: (2020)

Clinicopathological characteristics of peripheral clinical stage IA lung adenocarcinoma with high Ki-67 expression
por: Liu, Zhan, et al.
Publicado: (2021)

The Value of CT-Based Radiomics for Predicting Spread Through Air Spaces in Stage IA Lung Adenocarcinoma
por: Han, Xiaoyu, et al.
Publicado: (2022)

Prognostic impact of noninvasive areas in resected pathological stage IA lung adenocarcinoma
por: Kinoshita, Fumihiko, et al.
Publicado: (2023)

Predictors of upstage and treatment strategies for stage IA lung cancers after sublobar resection for adenocarcinoma in situ and minimally invasive adenocarcinoma
por: Su, Hang, et al.
Publicado: (2021)

Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma
por: Yu, Mei, et al.
Publicado: (2020)

Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma
por: Wang, Chao, et al.
Publicado: (2021)

Oncologic and obstetric outcomes after conization for adenocarcinoma in situ or stage IA1 cervical cancer
por: Wang, Xiaoyu, et al.
Publicado: (2020)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021)

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer
por: Wang, Qiang, et al.
Publicado: (2021)

Predictive factors of recurrence after resection of subsolid clinical stage IA lung adenocarcinoma
por: Im, Dong Jin, et al.
Publicado: (2021)

Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study
por: Huang, Zhixin, et al.
Publicado: (2023)

Significance of histologic subtype size as a prognostic indicator in stage IA lung adenocarcinoma
por: Jeon, Hyun Woo, et al.
Publicado: (2023)

Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non‐small cell lung cancer
por: Duan, Jin, et al.
Publicado: (2022)

Transcriptional Characterization Of The Tumor Immune Microenvironment And Its Prognostic Value For Locally Advanced Lung Adenocarcinoma In A Chinese Population
por: Chen, Yuqiao, et al.
Publicado: (2019)

A Nomogram Based on Consolidation Tumor Ratio Combined with Solid or Micropapillary Patterns for Postoperative Recurrence in Pathological Stage IA Lung Adenocarcinoma
por: Zhang, Longfu, et al.
Publicado: (2023)

Predictive value of radiological features on spread through air space in stage cIA lung adenocarcinoma
por: Zhang, Zhenrong, et al.
Publicado: (2020)

Development and validation of a nomogram based on preoperative variables for predicting recurrence‐free survival in stage IA lung adenocarcinoma
por: Xu, Jiaxi, et al.
Publicado: (2023)

Heterogeneity in intracranial relapses after complete resection of lung adenocarcinoma: Distinct features of brain‐only relapse versus synchronous extracranial relapse
por: Xu, Fei, et al.
Publicado: (2023)

Deep learning-enhanced radiomics for histologic classification and grade stratification of stage IA lung adenocarcinoma: a multicenter study
por: Pei, Guotian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vr3qjavml2jjt9434ro4e9db32